Pedro Henrique de Souza Wagner

9PUBLICATIONS
28CO-AUTHORS
Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 16, 2026
Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.

Francisco Cezar Aquino de Moraes, Pedro Henrique de Souza Wagner, Rosario Dominguez Crespo Hirata

|Dec 23, 2025
Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis.

Pedro Henrique de Souza Wagner, Gustavo Tadeu Freitas Uchôa Matheus, Danilo Monteiro Ribeiro

|Oct 17, 2025
Impact of TP53 somatic mutations on prognosis in endometrial cancer: a systematic review and meta-analysis.

Nayara Rozalem Moretti, Hideki Zimermann Kamitani, Pedro Henrique de Souza Wagner

|Jul 31, 2025
Clinical outcomes after switching from fingolimod to B-cell-depleting therapies in multiple sclerosis: systematic review and meta-analysis.

Pedro Henrique de Souza Wagner, Felipe Alves de Paiva, Julia Scaramal Mello

|Jul 15, 2025
Prognostic Significance of Circulating Tumor DNA Mutations in Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis Based on Time-To-Event Data.

Gustavo Tadeu Freitas Uchôa Matheus, Danilo Monteiro Ribeiro, Ana Luiza Rocha Soares Menegat

Pageof 2